Table 1.
Effects of NSAIDs and other analgesics on treatment response to citalopram in humans
| Remission | No Remission | remission rate (%) | P value | |
| NSAID | 182 | 227 | 44.5 | P = 0.0002 |
| No NSAID | 628 | 509 | 55.2 | |
| Analgesic | 52 | 88 | 37.1 | P = 0.0002 |
| No analgesic | 758 | 648 | 53.9 | |
| Both (NSAID and analgesic) | 23 | 40 | 36.5 | P = 0.0138 |
| None | 787 | 696 | 53.1 | |
| Either (NSAID or analgesic) | 211 | 275 | 43.4 | P < 0.0001 |
| None | 599 | 461 | 56.5 | |
| Vitamins | 44 | 31 | 58.7 | P = 0.2874 |
| No vitamins | 766 | 705 | 52.1 |
Number of patients in remission or not in remission at the end of 12 wk of treatment with citalopram shown as a function of presence or absence of various concomitant treatments. Data were analyzed using Fisher's exact test; P < 0.05 indicated a statistically significant relationship between the concomitant medication and the treatment outcome.